ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693543 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693543; 2) Community: the network communities that were significantly associated with the response to NSC 693543; 3) Molecule: the relationships between components within communities and NSC 693543; 4) MDR: the compounds that were significantly associated with the NSC 693543.

NSC Compound Enrichment Correlation
NSC 620256 Platinate(2-), tetrachloro-, (SP-4-1), 9-hydroxy-2,5,11- trimethyl-6H-pyrido[4,3-b]carbazolium (1:2) 0.00423163567577548 0.74262198
NSC 633273 ANTINEOPLASTIC-633273 0.00423163567577548 0.022706107
NSC 638038 Null 0.00423163567577548 -0.099119374
NSC 668332 Null 0.00423163567577548 -0.069120395
NSC 668335 Null 0.00423163567577548 0.0097672608
NSC 681646 Camptothecin Derivative 0.00423163567577548 0.31504934
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.00423163567577551 0.14665941
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.00423163567577551 -0.21846465
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.00550789647802199 0.40052863
NSC 176323 Camptothecin Derivative 0.00550789647802199 0.18714781
Total:62  Current:7    [First] [Prev] [Next] [Last]